Every Form 4 that Eastman Chemical Company (EMN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow EMN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EMN filings page.
Eastman Chemical senior vice president Adrian James Holt received an equity award linked to company performance. On 02/11/2026, Holt acquired 2,297 shares of Eastman Chemical common stock at a price of $0 per share. These shares were granted following the determination of performance shares earned for the three-year 2023–2025 performance period, and are held as direct beneficial ownership.
Eastman Chemical CEO and Board Chair Mark J. Costa reported an insider equity transaction involving company stock on February 4, 2026. He exercised 48,649 employee stock options at an exercise price of $65.16 per share, receiving the same number of Eastman Chemical common shares.
A portion of these shares, 43,638, was withheld by Eastman Chemical to cover the option exercise price and tax withholding obligations in a net exercise, which the filing states does not represent a sale by Costa. After these transactions, Costa directly owned 458,997 shares of common stock, with an additional 3,231 shares held indirectly through an ESOP.
Eastman Chemical Company’s EVP and CFO, William Thomas McLain Jr., reported an option-related share transaction. On 02/04/2026 he exercised employee stock options for 3,013 shares of common stock at an exercise price of $65.16 per share.
To cover the option exercise price and tax withholding in a “net exercise,” 2,636 shares were withheld by Eastman Chemical and not sold on the market. After these transactions, he directly beneficially owned 53,901 shares of Eastman Chemical common stock.
Eastman Chemical Company reported an equity award to executive officer Stephen G. Crawford, EVP, Technology Projects. On 01/02/2026, he received 34,193 restricted stock units (RSUs), each representing a contingent right to receive one share of Eastman Chemical common stock. These RSUs were reported as derivative securities beneficially owned directly.
The RSUs carry a conversion price of $0 and are scheduled to vest and pay out in unrestricted shares of common stock on February 2, 2027, subject to Mr. Crawford’s continued employment. After this grant, he beneficially owns 34,193 derivative securities in the form of RSUs tied to Eastman Chemical common stock.
Damon J. Audia, a director of Eastman Chemical Co. (EMN), reported crediting of 1,360 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan. The report shows two entries: 873 units credited at a market-linked value of $62.35 each and 487 units credited with a $0 price (automatic deferral), totaling 1,360 units beneficially owned following the transactions. These phantom units mirror the market value of one share each but are payable only in cash after the director's service ends, and thus do not represent actual shares with voting rights.
The Form 4 was filed as a single reporting person filing and signed by power of attorney on 10/09/2025. The entries reflect voluntary and automatic deferrals of director retainer fees into the director's deferred stock account rather than open-market purchases or option exercises.
Eastman Chemical (EMN) director Renee J. Hornbaker reported an automatic deferral under the Directors' Deferred Compensation Plan. On 10/07/2025, she was credited with 487 phantom stock units (value equal to one share of common stock), at a price of $0, reflecting a portion of her annual retainer fees. Phantom units are payable only in cash after service as a director ends.
Following the transaction, she beneficially owned 49,781 derivative securities. This total includes 1,151 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.
Eastman Chemical (EMN) director Linnie M. Haynesworth reported acquiring 487 Phantom Stock Units on 10/07/2025 at $0, reflecting an automatic deferral of a portion of her annual director retainer into the Directors' Deferred Compensation Plan. After the transaction, she beneficially owns 3,559 phantom units. Each unit has a value equal to one share of common stock and is payable only in cash after her service as a director ends. The total includes 42 units credited since May 1, 2025 as hypothetical reinvestment of dividend equivalents.
Director Eric L. Butler received 487 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan; each unit tracks one share of common stock and is payable in cash only after he leaves board service. Those units were credited via an automatic deferral of part of his annual retainer and include 53 units credited since 04/07/2025 as hypothetical reinvestment of dividend equivalents. After this transaction, Mr. Butler beneficially owns 2,768 shares (direct). The reported price per unit/share for the transaction is $0, reflecting an internal accounting credit rather than an open-market purchase. The filing was signed by a power of attorney on behalf of Mr. Butler on 10/09/2025.
Insider filing for Eastman Chemical Co. (EMN) reports that director Julie Fasone received 487 phantom stock units under the Directors' Deferred Compensation Plan on 10/07/2025. These units mirror the market value of one share each and are payable only in cash after she leaves board service. The filing shows 14,377 common-stock-equivalent units beneficially owned after the transaction, which includes 324 units credited since 04/07/2025 from reinvested dividend equivalents. The 487 units represent an automatic deferral of part of her annual retainer that would otherwise have been paid in cash. The filing was signed by a power of attorney on 10/09/2025.
James J. O'Brien, a director of Eastman Chemical Co. (EMN), acquired 487 phantom stock units under the company's Directors' Deferred Compensation Plan on 10/07/2025. These units are valued like common shares but are payable only in cash after he leaves board service. The report shows 17,407 shares (or equivalent units) beneficially owned following the transaction, which includes 395 additional units credited since 04/07/2025 from reinvested dividend equivalents. The 487 units arose from an automatic deferral of part of his annual retainer that would otherwise have been paid in cash; the per‑unit price for the phantom units is reported as $0 for administrative reporting purposes.
Eastman Chemical (EMN) director transaction: On 10/07/2025, a director acquired 487 phantom stock units under the Directors' Deferred Compensation Plan, recorded at $0 as an automatic deferral of a portion of annual retainer fees. Following this, the director beneficially owned 1,267 phantom stock units. These units track the value of common stock and are payable only in cash after the director’s service ends. The total includes 19 units credited since April 7, 2025 from dividend-equivalent reinvestments.
Brett D. Begemann, a director of Eastman Chemical Co. (EMN), received a total of 1,827 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan. These units represent cash‑payable credits tied to the issuer's common stock and were recorded as voluntary and automatic deferrals of director retainer fees; 1,340 units were a voluntary deferral and 487 units an automatic deferral. The filing shows 55,811 common‑share equivalents beneficially owned after the transaction, which includes 1,178 units from reinvested dividend equivalents credited since 05/01/2025. The units have no exercise price and are payable only in cash after termination of director service.
Insider transaction summary: A director of Eastman Chemical Co. (EMN) recorded a non‑cash acquisition of 487 phantom stock units on 10/07/2025. The units were credited under the Directors' Deferred Compensation Plan as an automatic deferral of a portion of annual retainer fees that would otherwise have been paid in cash. Phantom units track the market value of one share and are payable in cash after the director's service ends. Following the transaction the reporting person beneficially owns 13,391 common‑stock‑equivalent units, which includes 268 units credited since 05/01/2025 for reinvested dividend equivalents.
Director Humberto P. Alfonso reported acquisitions of phantom stock units under the company's Directors' Deferred Compensation Plan that convert to cash after he leaves the board. On 10/07/2025 he voluntarily deferred 1,178 units (valued at $62.35 each in the filing) and had an automatic deferral of 487 units, for a total of 1,665 newly credited phantom units.
Following these entries, he beneficially owns 53,576 shares (or share-equivalents) in a direct form. The filing notes 1,130 additional units credited since 5/01/2025 from hypothetical reinvestment of dividend equivalents. The units are payable only in cash under the plan.
Michelle H. Caveness, Senior Vice President and Chief Manufacturing Officer of Eastman Chemical Co. (EMN), reported changes in her beneficial ownership on transactions dated 10/01/2025. She received a payout of 6,715 restricted stock units (RSUs) upon completion of a three-year vesting period, recorded as an acquisition. Simultaneously, 1,636 shares were withheld to satisfy tax liabilities at a reported price of $61.96 per share. After these transactions the filing shows 6,246 shares beneficially owned. The Form 4 was signed by power of attorney on 10/02/2025.